Volume 100, 2004
From the journal:

Annual Reports Section "A" (Inorganic Chemistry)

30  Inorganic pharmaceuticals

P. J. Blowera  

a Nuclear Medicine Department, East Kent Hospitals NHS Trust, Kent and Canterbury Hospital, Canterbury, UK

Abstract

Recent landmarks in pharmaceutical use of inorganic elements include radioactive and paramagnetic tracers for tracking living cell movement in vivo, and FDA approval of the first yttrium-90 labelled therapeutic antibody.

About
Cited by
Related
Download options Please wait...

Article information

DOI
https://doi.org/10.1039/B312109G
Article type
Review Article
Submitted
23 Apr 2004
Accepted
23 Apr 2004
First published
20 Oct 2004

Annu. Rep. Prog. Chem., Sect. A: Inorg. Chem., 2004,100, 633-658

Permissions

Request permissions

30  Inorganic pharmaceuticals

P. J. Blower, Annu. Rep. Prog. Chem., Sect. A: Inorg. Chem., 2004, 100, 633 DOI: 10.1039/B312109G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements